- Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
Ming Zhao et al, 2023, npj Breast Cancer CrossRef - Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma
Xiaoshuang Kong et al, 2023, Cancer Medicine CrossRef